NASDAQ: AKBA
Akebia Therapeutics Inc Earnings Dates, Reports, Calls

Akebia Therapeutics earnings were -$45.3M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest AKBA earnings report on Mar 31, 2025 announced Q1 2025 earnings of $6.1M, down 126.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AKBA reported annual earnings of -$69.4M, with 33.7% growth.

AKBA earnings history

Current Revenue
$184.9M
Current Earnings
-$45.3M
Current Profit Margin
-24.5%

AKBA Return on Equity

Current Company
N/A
Current Industry
-60.2%
Current Market
31.3%

AKBA undefined

Current Company
-18.9%
Current Industry
-2.5%
AKBA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AKBA announces earnings.

AKBA undefined

Current Company
-9.98%
Current Industry
5.8%
AKBA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AKBA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AKBA$10.87M-$45.31MN/A-$0.22
PHVS-$189.22M-$171.40MN/A-$3.16
NTLA-$515.64M-$525.91MN/A-$5.22
ARDX-$31.70M-$53.76MN/A-$0.22
ELVN-$93.96M-$94.83MN/A-$1.92

Akebia Therapeutics Earnings Reports & History FAQ

What were Akebia Therapeutics's earnings last quarter?

On AKBA's earnings call on Invalid Date, Akebia Therapeutics (NASDAQ: AKBA) reported Q1 2025 earnings per share (EPS) of $0.03, up 133.33% year over year. Total AKBA earnings for the quarter were $6.11 million. In the same quarter last year, Akebia Therapeutics's earnings per share (EPS) was -$0.09.

If you're new to stock investing, here's how to buy Akebia Therapeutics stock.

Is Akebia Therapeutics profitable or losing money?

As of the last Akebia Therapeutics earnings report, Akebia Therapeutics is currently losing money. Akebia Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$45.31 million, a 5.3% increase year over year.

What was AKBA's earnings growth in the past year?

As of Akebia Therapeutics's earnings date in Invalid Date, Akebia Therapeutics's earnings has grown year over year. AKBA earnings in the past year totalled -$45.31 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.